Advocacy intelligence hub — real-time data for patient organizations
Axovia Therapeutics — EARLY_PHASE1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology — PHASE2
Rolfs Consulting und Verwaltungs-GmbH (RCV)
Marshfield Clinic Research Foundation
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
IMCIVREE
Rhythm Pharmaceuticals, Inc
IMCIVREE
(SETMELANOTIDE)standardRhythm Pharmaceuticals, Inc
Melanocortin 4 Receptor Agonist [EPC]
12.1 Mechanism of Action Setmelanotide is an MC4 receptor agonist with 20-fold less activity at the melanocortin 3 (MC3) and melanocortin 1 (MC1) rece...
Hélène Dollfus, MD
Fédération Génétique
Leslie G Biesecker, M.D., MD
National Human Genome Research Institute (NHGRI)
📍 BETHESDA, MD
J-Louis Mandel, MD
IGBMC
Alain Verloes, MD
Unité de Génétique Robert Debré
Didier Lacombe, MD
Service de Génétique Médicale/Bordeaux
Christian Brandt, MD
CIC Strasbourg